PMC:7435837 / 8798-9050 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T83","span":{"begin":2,"end":9},"obj":"Body_part"},{"id":"T84","span":{"begin":111,"end":118},"obj":"Body_part"},{"id":"T85","span":{"begin":159,"end":167},"obj":"Body_part"}],"attributes":[{"id":"A83","pred":"fma_id","subj":"T83","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A84","pred":"fma_id","subj":"T84","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A85","pred":"fma_id","subj":"T85","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"l protein of new viruses [34]. Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. Some investigated drugs have been reviewed as protease inhibitors agai"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T15","span":{"begin":102,"end":110},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"l protein of new viruses [34]. Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. Some investigated drugs have been reviewed as protease inhibitors agai"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T112","span":{"begin":17,"end":24},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T113","span":{"begin":26,"end":28},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T114","span":{"begin":81,"end":89},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"l protein of new viruses [34]. Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. Some investigated drugs have been reviewed as protease inhibitors agai"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T87","span":{"begin":2,"end":9},"obj":"Chemical"},{"id":"T88","span":{"begin":45,"end":54},"obj":"Chemical"},{"id":"T89","span":{"begin":111,"end":118},"obj":"Chemical"},{"id":"T90","span":{"begin":159,"end":167},"obj":"Chemical"},{"id":"T91","span":{"begin":200,"end":205},"obj":"Chemical"},{"id":"T92","span":{"begin":228,"end":247},"obj":"Chemical"},{"id":"T94","span":{"begin":237,"end":247},"obj":"Chemical"}],"attributes":[{"id":"A87","pred":"chebi_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A88","pred":"chebi_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A90","pred":"chebi_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A93","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A94","pred":"chebi_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"l protein of new viruses [34]. Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. Some investigated drugs have been reviewed as protease inhibitors agai"}

{"project":"LitCovid-PubTator","denotations":[{"id":"187","span":{"begin":153,"end":158},"obj":"Gene"},{"id":"190","span":{"begin":102,"end":110},"obj":"Species"},{"id":"192","span":{"begin":31,"end":40},"obj":"Chemical"},{"id":"193","span":{"begin":45,"end":54},"obj":"Chemical"}],"attributes":[{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"Gene:43740568"},{"id":"A190","pred":"tao:has_database_id","subj":"190","obj":"Tax:694009"},{"id":"A192","pred":"tao:has_database_id","subj":"192","obj":"MESH:D019438"},{"id":"A193","pred":"tao:has_database_id","subj":"193","obj":"MESH:D061466"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"l protein of new viruses [34]. Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. Some investigated drugs have been reviewed as protease inhibitors agai"}

{"project":"LitCovid-sentences","denotations":[{"id":"T70","span":{"begin":31,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"l protein of new viruses [34]. Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. Some investigated drugs have been reviewed as protease inhibitors agai"}

{"project":"2_test","denotations":[{"id":"32731428-15200845-71421276","span":{"begin":26,"end":28},"obj":"15200845"},{"id":"32731428-15878786-71421277","span":{"begin":56,"end":58},"obj":"15878786"}],"text":"l protein of new viruses [34]. Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. Some investigated drugs have been reviewed as protease inhibitors agai"}